Evaluation of the abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the roche TaqMan HCV analyte-specific reagent assay

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 2872-2878

  Pyne, Michael T ^a   Konnick, Eric Q ^a,b   Phansalkar, Amit ^a,c   Hillyard, David R ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Cytel Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LINEAR REGRESSION ANALYSIS; NONHUMAN; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REFERENCE VALUE; REPRODUCIBILITY; STANDARD; VIRUS HEPATITIS; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 69949099265     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02329-08     Document Type: Article

References (14)

1. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310. (Pubitemid 16134762)
2. Braun, P., R. Ehret, F. Wiesmann, F. Zabbai, M. Knickmann, R Kühn, S. Thamm, G. Warnat, and H. Knechten. 2007. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin. Chem. Lab. Med. 45:93-99.
3. Caliendo, A. M., A. Valsamakis, Y. Zhou, B. Yen-Lieberman, J. Andersen, S. Young, A. Ferreira-Gonzalez, G. J. Tsongalis, R. Pyles, J. W. Bremer, and N. S. Lurain. 2006. Multilaboratory comparison of hepatitis C virus viral load assays. J. Clin. Microbiol. 44:1726-1732.
4. Elbeik, T., R. Dalessandro, R. A. Loftus, and S. Beringer. 2007. HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus realtime PCR AmpliPrep/TaqMan test. Expert Rev. Mol. Diagn. 7:723-753.
5. Halfon, P., G. Pénaranda, M. Bourlière, H. Khiri, M.-F. Masseyeff, and D. Ouzan. 2006. Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection. J. Med. Virol. 78:208-215.
6. Halfon, P., M. Bourlière, G. Pénaranda, H. Khiri, and D. Ouzan. 2006. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J. Clin. Microbiol. 44:2507-2511.
7. Konnick, E. Q., S. M. Williams, E. R. Ashwood, and D. R. Hillyard. 2005. Evaluation of the COBAS hepatitis C virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays. J. Clin. Microbiol. 43:2133-2140.
8. Michelin, B. D. A., Z. Muller, E. Stelzl, E. Marth, and H. H. Kessler. 2007. Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA. J. Clin. Virol. 38:96-100.
9. Saldanha, J., A. Heath, C. Aberham, J. Albrecht, G. Gentili, M. Gessner, and G. Pisani. 2005. World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays. Vox Sang. 88:202-204. (Pubitemid 40516268)
10. Sarrazin, C., B. C. Gärtner, D. Sizmann, R. Babiel, U. Mihm, W. P. Hofmann, M. von Wagner, and S. Zeuzem. 2006. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. J. Clin. Microbiol. 44:729-737.
11. Sarrazin, C., D. A. Hendricks, F. Sedarati, and S. Zeuzem. 2001. Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon α-2a. J. Clin. Microbiol. 39:2850-2855.
12. Sloma, C. R., J. J. Germer, T. M Gerads, J. N. Mandrekar, P. S. Mitchell, and J. D. C. Yao. 2009. Comparison of the Abbott RealTime human immunodeficiency virus type 1 (HIV-1) assay and the COBAS AmpliPrep/COBAS TaqMan HIV-1 test: workflow, reliability, and direct costs. J. Clin. Microbiol. doi:10.1128/JCM.02231-08.
13. Vermehren, J., A. Kau, B. C. Gärtner, R. Göbel, S. Zeuzem, and C. Sarrazin. 2008. Differences between two real-time PCR based assays (RealTime HCV, COBAS Ampliprep/COBAS TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for HCV RNA detection and quantification. J. Clin. Microbiol. 46:3880-3891.
14. Wolff, D., and A. Gerritzen. 2007. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS TaqMan and Abbott RealTime test assays for quantification of hepatitis C virus and HIV RNA. Clin. Chem. Lab. Med. 45:917-922.